Extracellular vesicle-associated miRNAs are an adaptive response to gestational diabetes mellitus

[1]  M. Lappas,et al.  Extracellular vesicles and their potential role inducing changes in maternal insulin sensitivity during gestational diabetes mellitus , 2020, American journal of reproductive immunology.

[2]  Xilin Yang,et al.  Development and validation of an early pregnancy risk score for the prediction of gestational diabetes mellitus in Chinese pregnant women , 2020, BMJ Open Diabetes Research & Care.

[3]  M. Lappas,et al.  Regulation of glucose homeostasis by small extracellular vesicles in normal pregnancy and in gestational diabetes , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  W. Lems,et al.  The Clinical Relevance of Hyperkyphosis: A Narrative Review , 2020, Frontiers in Endocrinology.

[5]  Li Li,et al.  MicroRNA-17-92 Regulates Beta-Cell Restoration After Streptozotocin Treatment , 2020, Frontiers in Endocrinology.

[6]  M. Turner,et al.  Letter to the editor in response to: Evidence in support of the international association of diabetes in pregnancy study groups' criteria for diagnosing gestational diabetes worldwide in 2019. , 2019, American journal of obstetrics and gynecology.

[7]  M. Hod,et al.  Evidence in support of the International Association of Diabetes in Pregnancy study groups' criteria for diagnosing gestational diabetes mellitus worldwide in 2019. , 2019, American journal of obstetrics and gynecology.

[8]  J. Zierath,et al.  Circulating Exosomal miR-20b-5p Is Elevated in Type 2 Diabetes and Could Impair Insulin Action in Human Skeletal Muscle , 2018, Diabetes.

[9]  Andrew Lai,et al.  Quantitative Proteomics by SWATH‐MS Suggest an Association Between Circulating Exosomes and Maternal Metabolic Changes in Gestational Diabetes Mellitus , 2018, Proteomics.

[10]  G. Rice,et al.  Human placental exosomes in gestational diabetes mellitus carry a specific set of miRNAs associated with skeletal muscle insulin sensitivity. , 2018, Clinical science.

[11]  Jing Xu,et al.  Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.

[12]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[13]  George A. Calin,et al.  Clinical utility of circulating non-coding RNAs — an update , 2018, Nature Reviews Clinical Oncology.

[14]  C. N. Ferreira,et al.  Proresolving protein Annexin A1: The role in type 2 diabetes mellitus and obesity. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[15]  Meiling Yan,et al.  MiRNA-92a protects pancreatic B-cell function by targeting KLF2 in diabetes mellitus. , 2018, Biochemical and biophysical research communications.

[16]  C. Théry,et al.  Why the need and how to approach the functional diversity of extracellular vesicles , 2017, Philosophical Transactions of the Royal Society B: Biological Sciences.

[17]  G. Rice,et al.  Placental Exosomes as Early Biomarker of Preeclampsia: Potential Role of Exosomal MicroRNAs Across Gestation , 2017, The Journal of clinical endocrinology and metabolism.

[18]  Asif Ahmed,et al.  Small Molecule, Big Prospects: MicroRNA in Pregnancy and Its Complications , 2017, Journal of pregnancy.

[19]  A. Brunetti,et al.  Gestational diabetes mellitus: an updated overview , 2017, Journal of Endocrinological Investigation.

[20]  D. Cohen,et al.  Publisher's Note , 2017, Neuroscience & Biobehavioral Reviews.

[21]  I. Witten,et al.  Data Mining, Fourth Edition: Practical Machine Learning Tools and Techniques , 2016 .

[22]  M. P. Koster,et al.  External validation of prognostic models to predict risk of gestational diabetes mellitus in one Dutch cohort: prospective multicentre cohort study , 2016, British Medical Journal.

[23]  H. Thomas,et al.  The JAK/STAT pathway in obesity and diabetes , 2016, The FEBS journal.

[24]  W. D. van Marken Lichtenbelt,et al.  Exosomal microRNA miR-92a concentration in serum reflects human brown fat activity , 2016, Nature Communications.

[25]  M. Portillo,et al.  Erratum to: MicroRNAs involved in the browning process of adipocytes , 2016, Journal of Physiology and Biochemistry.

[26]  S. Thériault,et al.  Early prediction of gestational diabetes: a practical model combining clinical and biochemical markers , 2016, Clinical chemistry and laboratory medicine.

[27]  M. Mitchell,et al.  Gestational Diabetes Mellitus Is Associated With Changes in the Concentration and Bioactivity of Placenta-Derived Exosomes in Maternal Circulation Across Gestation , 2015, Diabetes.

[28]  Jie Wu,et al.  The role, mechanism and potentially novel biomarker of microRNA-17-92 cluster in macrosomia , 2015, Scientific Reports.

[29]  Eran Hadar,et al.  The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care # , 2015, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[30]  Miharu Kobayashi,et al.  The Effect of Glucose on the Release and Bioactivity of Exosomes From First Trimester Trophoblast Cells. , 2015, The Journal of clinical endocrinology and metabolism.

[31]  Ling Zhou,et al.  A MicroRNA Signature in Gestational Diabetes Mellitus Associated with Risk of Macrosomia , 2015, Cellular Physiology and Biochemistry.

[32]  D. Wright,et al.  Competing risks model in screening for preeclampsia by maternal characteristics and medical history. , 2015, American journal of obstetrics and gynecology.

[33]  A. Baschat,et al.  First trimester prediction of maternal glycemic status , 2015, Journal of perinatal medicine.

[34]  Jidong Cheng,et al.  AMPD1: a novel therapeutic target for reversing insulin resistance , 2014, BMC Endocrine Disorders.

[35]  C. Andersen,et al.  Brown Adipose Tissue Improves Whole-Body Glucose Homeostasis and Insulin Sensitivity in Humans , 2014, Diabetes.

[36]  Miharu Kobayashi,et al.  A Gestational Profile of Placental Exosomes in Maternal Plasma and Their Effects on Endothelial Cell Migration , 2014, PloS one.

[37]  G. Roglić,et al.  Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. , 2014, Diabetes research and clinical practice.

[38]  Sophie Rome,et al.  Profiling of Circulating MicroRNAs Reveals Common MicroRNAs Linked to Type 2 Diabetes That Change With Insulin Sensitization , 2014, Diabetes Care.

[39]  Andrew F. Hill,et al.  Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles , 2014, Journal of extracellular vesicles.

[40]  Lesley Cheng,et al.  Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood , 2014, Journal of extracellular vesicles.

[41]  F. Sánchez‐Madrid,et al.  Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs , 2013, Nature Communications.

[42]  T. Hayek,et al.  Paraoxonase1 (PON1) reduces insulin resistance in mice fed a high-fat diet, and promotes GLUT4 overexpression in myocytes, via the IRS-1/Akt pathway. , 2013, Atherosclerosis.

[43]  Sugunavathi Sepramaniam,et al.  miR-25 and miR-92a regulate insulin I biosynthesis in rats , 2013, RNA biology.

[44]  R. Moses,et al.  Testing for Gestational Diabetes Mellitus in Australia , 2013, Diabetes Care.

[45]  J. Zierath,et al.  Constitutive STAT3 Phosphorylation Contributes to Skeletal Muscle Insulin Resistance in Type 2 Diabetes , 2013, Diabetes.

[46]  Lynne T. Bemis,et al.  Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.

[47]  Jingyan Dong,et al.  Early Second-Trimester Serum MiRNA Profiling Predicts Gestational Diabetes Mellitus , 2011, PloS one.

[48]  K. Nicolaides,et al.  Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks , 2011, Prenatal diagnosis.

[49]  P. Catalano.  Obesity, insulin resistance, and pregnancy outcome. , 2010, Reproduction.

[50]  R. DeFronzo,et al.  Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes , 2009, Diabetes Care.

[51]  J. Dungan,et al.  Hyperglycemia and Adverse Pregnancy Outcomes , 2009 .

[52]  Bengt Persson,et al.  Hyperglycemia and Adverse Pregnancy Outcomes , 2009 .

[53]  A. Dyer,et al.  Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study , 2008, Diabetes.

[54]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[55]  R. DeFronzo,et al.  Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects. , 2005, The Journal of clinical endocrinology and metabolism.

[56]  D. Hilton,et al.  A New Role for SOCS in Insulin Action , 2003, Science's STKE.

[57]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.

[58]  J. de Vellis,et al.  JAK/STAT signaling pathway mediates cytokine‐induced iNOS expression in primary astroglial cell cultures , 2001, Journal of neuroscience research.

[59]  E. Reece,et al.  Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. , 2001, The Journal of clinical endocrinology and metabolism.

[60]  S. Akira,et al.  Signal Transducer and Activator of Transcription (Stat)-Induced Stat Inhibitor 1 (Ssi-1)/Suppressor of Cytokine Signaling 1 (Socs1) Inhibits Insulin Signal Transduction Pathway through Modulating Insulin Receptor Substrate 1 (Irs-1) Phosphorylation , 2001, The Journal of experimental medicine.

[61]  A. Baron,et al.  Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. , 2000, Diabetes.

[62]  W. Alexander,et al.  Gigantism in mice lacking suppressor of cytokine signalling-2 , 2000, Nature.

[63]  E. Van Obberghen,et al.  SOCS-3 Is an Insulin-induced Negative Regulator of Insulin Signaling* , 2000, The Journal of Biological Chemistry.

[64]  S.-M. Kim,et al.  Glycation impairs high-density lipoprotein function , 2000, Diabetologia.

[65]  Lloyd A. Smith,et al.  Feature Selection for Machine Learning: Comparing a Correlation-Based Filter Approach to the Wrapper , 1999, FLAIRS.

[66]  S. Amini,et al.  Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. , 1999, American journal of obstetrics and gynecology.

[67]  B. R. Dey,et al.  Interaction of Human Suppressor of Cytokine Signaling (SOCS)-2 with the Insulin-like Growth Factor-I Receptor* , 1998, The Journal of Biological Chemistry.

[68]  H. Stähelin.  Guidelines , 1994, Communicating Science.

[69]  S. Shapiro,et al.  An Analysis of Variance Test for Normality (Complete Samples) , 1965 .

[70]  H. B. Mann,et al.  On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other , 1947 .

[71]  Trond Petersen.  Analyzing Panel Data: Fixed- and Random-Effects Models , 2004 .

[72]  W. Lopaczynski.  Differential regulation of signaling pathways for insulin and insulin-like growth factor I. , 1999, Acta biochimica Polonica.

[73]  Electronic Supplementary Material -methods , 2022 .